Meeting
2023 ASCO Annual Meeting
Two-year lung cancer survival between 2000 to 2020: Results from 3 French nationwide cohorts.
Authors
Didier Debieuvre
Service de Pneumologie, Groupe Hospitalier de la Région Mulhouse Sud-Alsace, hôpital Émile-Muller, Mulhouse, France
Didier Debieuvre , Isabelle Monnet , Olivier Bylicki , Sophie Schneider , Francois Goupil , Benoit Godbert , Christine Dussopt , Herve Pegliasco , Laurent Portel , Reda Chikouche , Philippe Masson , Mohamad Jaafar , Clothilde Marty , Fethi EL Khanjari , Julie Obert , Marjorie Picaud , Anne Sophie Bravard , Herve Le Floch , Alexia Letierce , Hugues Morel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 8542)
DOI
10.1200/JCO.2023.41.16_suppl.8542
Abstract #
8542
Poster Bd #
169
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The intersection of neighborhood-level disadvantage and overall lung cancer survival.
First Author: Kathleen Kennedy
Poster
2019 ASCO Quality Care Symposium
Impact of dual-eligible status on survival in Medicare patients with lung cancer.
First Author: Meera Vimala Ragavan
Poster
2013 ASCO Annual Meeting
Social inequality in survival after lung cancer: The attribution of stage at diagnosis, receipt of treatment, and comorbidity in a Danish nationwide clinical database study.
First Author: Susanne O. Dalton
Poster
2012 ASCO Annual Meeting
The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients.
First Author: MARK Krasnik